adplus-dvertising
Connect with us

Investment

Cannabis Investment Opportunities Beyond North America’s Borders

Published

 on

Stockhouse cannabis sector investors have watched Canada’s domestic companies take a sometimes rickety rollercoaster ride over the past 12 to 18 months. But the nausea that cannabis can often effectively treat patients can’t necessarily help with the motion sickness investors have felt watching their stocks tumble in the face of a myriad problems licensed producers, cultivators and retailers have faced, and created, over that time.

As a result, savvy investors in the cannabis space are beginning to look outside the box, errr borders, for bona fide opportunities in places some may consider off the beaten path. Like…Latin America.

Did you know that Canada was not the first country to legalize recreational, adult-use cannabis at the federal level? In fact, the South American country of Uruguay passed legislation to legalize recreational cannabis in December 2013, making it the first country in the modern era to legalize cannabis (almost 5 years prior to Canada). Fast- forward to today and you’ll find that Colombia has positioned itself as the newest major player on the Latin American cannabis landscape.

According to Prohibition Partners, Latin America is among the world’s fastest-growing cannabis markets with expected cannabis spending of USD$12-billion by 2028, and an estimated 68 million potential medicinal cannabis patients.

Colombia started along a path toward legalization in 1986, and now has one of the most sophisticated regulatory systems in the continent. The country boasts an ideal climate for cultivation of the plant, tolerant legislation, and low production costs that have recently turned the South American nation into a major hub for international cannabis investments. Today, the local industry is dominated by a few players that have attracted investor attention above others.

One such player is Blueberries Medical Corp. (BBM) (CSE: BBM, OTC: BBRRF, FRA: 1OA, Forum) – a Latin American licensed producer of medicinal cannabis and cannabis-derived products, operating mainly out of the Bogotá Savannah of central Colombia.

Commencing trading on the Canadian Securities Exchange in February 2019, BBM has quickly gained the attention of both public retail and private institutional investment communities in South and North America, as reported in a Stockhouse Top Value Stock Editorial in June.

This innovative Colombian-based company has distinction of being the first Company to have designed and engineered a machine with new stainless-steel extraction vessels that is fully compliant under European Union’s Good Manufacturing Practices (EU-GMP). They also boast 142 exclusive Colombian cannabis strains with high CBD and THC contents with all of the applicable licenses granted by the Colombian Ministries of Justice and Health.

Blueberries Medical Corp. has made a number of strategic moves over the past 18 months to help grow its business and brand globally. Stockhouse investors who’ve traditionally kept a keen eye to North American-only cannabis companies, may want to take a long, hard look at this value opportunity stock.

FULL DISCLOSURE: Blueberries Medical Corp. is a paid client of Stockhouse Publishing.

New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.

Source:- Stockhouse

Source link

Continue Reading

Economy

S&P/TSX composite down more than 200 points, U.S. stock markets also fall

Published

 on

 

TORONTO – Canada’s main stock index was down more than 200 points in late-morning trading, weighed down by losses in the technology, base metal and energy sectors, while U.S. stock markets also fell.

The S&P/TSX composite index was down 239.24 points at 22,749.04.

In New York, the Dow Jones industrial average was down 312.36 points at 40,443.39. The S&P 500 index was down 80.94 points at 5,422.47, while the Nasdaq composite was down 380.17 points at 16,747.49.

The Canadian dollar traded for 73.80 cents US compared with 74.00 cents US on Thursday.

The October crude oil contract was down US$1.07 at US$68.08 per barrel and the October natural gas contract was up less than a penny at US$2.26 per mmBTU.

The December gold contract was down US$2.10 at US$2,541.00 an ounce and the December copper contract was down four cents at US$4.10 a pound.

This report by The Canadian Press was first published Sept. 6, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

S&P/TSX composite up more than 150 points, U.S. stock markets also higher

Published

 on

 

TORONTO – Canada’s main stock index was up more than 150 points in late-morning trading, helped by strength in technology, financial and energy stocks, while U.S. stock markets also pushed higher.

The S&P/TSX composite index was up 171.41 points at 23,298.39.

In New York, the Dow Jones industrial average was up 278.37 points at 41,369.79. The S&P 500 index was up 38.17 points at 5,630.35, while the Nasdaq composite was up 177.15 points at 17,733.18.

The Canadian dollar traded for 74.19 cents US compared with 74.23 cents US on Wednesday.

The October crude oil contract was up US$1.75 at US$76.27 per barrel and the October natural gas contract was up less than a penny at US$2.10 per mmBTU.

The December gold contract was up US$18.70 at US$2,556.50 an ounce and the December copper contract was down less than a penny at US$4.22 a pound.

This report by The Canadian Press was first published Aug. 29, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Investment

Crypto Market Bloodbath Amid Broader Economic Concerns

Published

 on

Breaking Business News Canada

The crypto market has recently experienced a significant downturn, mirroring broader risk asset sell-offs. Over the past week, Bitcoin’s price dropped by 24%, reaching $53,000, while Ethereum plummeted nearly a third to $2,340. Major altcoins also suffered, with Cardano down 27.7%, Solana 36.2%, Dogecoin 34.6%, XRP 23.1%, Shiba Inu 30.1%, and BNB 25.7%.

The severe downturn in the crypto market appears to be part of a broader flight to safety, triggered by disappointing economic data. A worse-than-expected unemployment report on Friday marked the beginning of a technical recession, as defined by the Sahm Rule. This rule identifies a recession when the three-month average unemployment rate rises by at least half a percentage point from its lowest point in the past year.

Friday’s figures met this threshold, signaling an abrupt economic downshift. Consequently, investors sought safer assets, leading to declines in major stock indices: the S&P 500 dropped 2%, the Nasdaq 2.5%, and the Dow 1.5%. This trend continued into Monday with further sell-offs overseas.

The crypto market’s rapid decline raises questions about its role as either a speculative asset or a hedge against inflation and recession. Despite hopes that crypto could act as a risk hedge, the recent crash suggests it remains a speculative investment.

Since the downturn, the crypto market has seen its largest three-day sell-off in nearly a year, losing over $500 billion in market value. According to CoinGlass data, this bloodbath wiped out more than $1 billion in leveraged positions within the last 24 hours, including $365 million in Bitcoin and $348 million in Ether.

Khushboo Khullar of Lightning Ventures, speaking to Bloomberg, argued that the crypto sell-off is part of a broader liquidity panic as traders rush to cover margin calls. Khullar views this as a temporary sell-off, presenting a potential buying opportunity.

Josh Gilbert, an eToro market analyst, supports Khullar’s perspective, suggesting that the expected Federal Reserve rate cuts could benefit crypto assets. “Crypto assets have sold off, but many investors will see an opportunity. We see Federal Reserve rate cuts, which are now likely to come sharper than expected, as hugely positive for crypto assets,” Gilbert told Coindesk.

Despite the recent volatility, crypto continues to make strides toward mainstream acceptance. Notably, Morgan Stanley will allow its advisors to offer Bitcoin ETFs starting Wednesday. This follows more than half a year after the introduction of the first Bitcoin ETF. The investment bank will enable over 15,000 of its financial advisors to sell BlackRock’s IBIT and Fidelity’s FBTC. This move is seen as a significant step toward the “mainstreamization” of crypto, given the lengthy regulatory and company processes in major investment banks.

The recent crypto market downturn highlights its volatility and the broader economic concerns affecting all risk assets. While some analysts see the current situation as a temporary sell-off and a buying opportunity, others caution against the speculative nature of crypto. As the market evolves, its role as a mainstream alternative asset continues to grow, marked by increasing institutional acceptance and new investment opportunities.

Continue Reading

Trending